ESRRA and obesity due to melanocortin 4 receptor deficiency: This is in agreement with the data in the current study linking obesity (associated with high blood cholesterol levels) to a higher expression of SOD2 and GSTM1, as detected by an increase in the levels of those two enzymes and ERRα in overweight/obese basal-like breast cancer patients compared to lean patients.